Expertise in
6
conditions

Sebastiaan I. Velthuis

Amersfoort, UT, NL 
Expertise in
6
conditions
Amersfoort, UT, NL 

Overview

Sebastiaan Velthuis practices practicing medicine in Amersfoort, Netherlands.

Mr. Velthuis is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Telangiectasia, Hereditary Hemorrhagic Telangiectasia, Pulmonary Arteriovenous Malformation (PAVM), and Pulmonary Arteriovenous Fistula.

He is actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Amersfoort, UT, Netherlands
Other Locations
Maastricht, LI, Netherlands
Leiden, ZH, Netherlands
St. Antonius Hospital
Nieuwegein, UT, Netherlands
Ede, GE 6716RP, Netherlands
Utrecht, UT, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3

28 Total Publications

Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score.
Predicting clinically relevant bleeding in new-onset atrial fibrillation patients initiating oral anticoagulant therapy: External validation of the AF-BLEED score.
Journal: Thrombosis research
Published: April 22, 2025

Frequently Asked Questions about Sebastiaan I. Velthuis

Is Sebastiaan I. Velthuis a top-rated expert for Telangiectasia?

MediFind is an objective health platform that identifies experts based on real-world data. Sebastiaan I. Velthuis is classified as an Distinguished expert for Telangiectasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sebastiaan I. Velthuis participate in research or clinical trials?

Yes. Sebastiaan I. Velthuis has published 28 articles and abstracts on conditions like Telangiectasia. You can view a list of Sebastiaan I. Velthuis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Velthuis's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile